MIRA — Mira Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Brief: MIRA Pharmaceuticals Secures Worldwide Exclusive Rights To MIRA-55 And SKNY-1 - SEC Filing
Brief: Mira Pharmaceuticals Enters Into Amendment No 1 To Exclusive License Agreement With Miralogx
Brief: Mira Pharmaceuticals Inc - Completes Phase 1 Dosing Of Ketamir-2 - SEC Filing
Brief: Mira Pharmaceuticals Inc - Initiates Phase 1 Study Of Ketamir-2 - SEC Filing
U.S. STOCKS ON THE MOVE-Bitfarms, Progyny, ManpowerGroup
U.S. STOCKS ON THE MOVE-DoorDash, Praxis, Snowflake
MIRA Pharmaceuticals jumps as oral pain drug beats morphine in animal study
Becton falls on CFO exit, preliminary Q4 revenue miss
U.S. STOCKS ON THE MOVE-United Airlines, Fossil Group, T-Mobile
U.S. STOCKS ON THE MOVE-Taiwan Semiconductor, HP, Salesforce
MIRA Pharmaceuticals jumps as oral pain drug beats morphine in animal study
Brief: Mira Pharmaceuticals Reports Positive PTSD Data For Ketamir-2 - SEC Filing
Mira Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Mira Pharmaceuticals Inc expected to post a loss of 13 cents a share - Earnings Preview
Brief: Mira Pharmaceuticals Inc - FDA Clears Mira's Ind For Ketamir-2 - SEC Filing
Mira Pharmaceuticals Jumps On Positive Preclinical Data From Marijuana: based pain relief drug
Brief: Mira Pharmaceuticals says Mira-55 Shows Morphine-Comparable Pain Relief Without Opioid Risks
Brief: Mira Pharmaceuticals Announces New Study Results For SKNY-1 - SEC Filing
Brief: Mira Pharmaceuticals Inc - Michelle Yanez Steps Down As CFO Of Mira Pharmaceuticals - SEC Filing